Caplin Point Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Small Cap

16 Apr 2021 | 03:59 PM

466.20
14.80 (3.28%)

  • Underperforms Index

    36.62%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 16.83%

  • More Volatile

    3.1%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.85%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

686

686.00

300

300.10

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Caplin Point Laboratories Ltd has decreased by -27.15% since past 3 Months

  • MF shareholding in Caplin Point Laboratories Ltd has increased by 20.45% since past 3 Months

  • FII shareholding in Caplin Point Laboratories Ltd has decreased by -77.96% since past 1 Year

  • MF shareholding in Caplin Point Laboratories Ltd has increased by 20905.6% since past 1 Year

Loading...